
Welcome to Cheng Lab
Way to go, more to come
The BioTherapeutics Laboratory is led by Dr. Ke Cheng. We are part of the Department of Biomedical Engineering at Columbia University, in the city of New York. Previously, BioTherapeutics Lab was part of the Department of Molecular and Biomedical Sciences at the North Carolina State University College of Veterinary Medicine as well as the Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University.
Our studies include regenerative medicine approaches by using patient-derived stem cells, biomaterials, and targeted nanoparticles. For stem cell research, we are interested in isolating patient-specific and organ-specific adult stem cells and testing their regenerative potential in small/large animal models of diseases. We are also taking an integrated approach that combines cells, biomaterials, nanoparticles, and other bioengineering approaches such as magnetic targeting to enhance the efficiency of stem cell therapies.
Latest news:
- Dr. Ke Cheng receives the AAEV Founder’s Award, and inducted into the inaugural class of AAEV Fellow
- Congratulations to Dr. Cheng for receiving the 2025 Clemson Award For Applied Research!
- Congratulations to Weihang for receiving the Alan L. Kaganov Fellowship
- Dr. Ke Cheng delivered the Archimedes Lecture and met with Carol Kaganov
- Dr. Ke Cheng Recognized among 2024 Highly Cited Researchers from Clarivate











